Roche posts results for satralizumab TED trial; completes Ocrelizumab SC vs IV MS studyAug 12Weekly roundup, 2 itemsocrelizumabRoche
Roche's SatraGO-1 posts completed Phase III results; CellCept gets four-formulation label updateJul 31Weekly roundup, 5 itemsmycophenolate mofetilRoche
Sign inSign in